(S (NP-SBJ Human/JJ T/NN cell/NN transcription/NN factor/NN GATA-3/NN) (VP stimulates/VBZ (NP HIV-1/NN expression/NN)) ./.)
(S (NP-SBJ-17 (NP (NP A/DT family/NN) (PP of/IN (NP transcriptional/JJ activating/VBG proteins/NNS))) ,/, (NP the/DT GATA/NN factors/NNS) ,/,) (VP has/VBZ (VP been/VBN (VP shown/VBN (S (NP-SBJ *-17/-NONE-) (VP to/TO (VP bind/VB (PP to/TO (NP a/DT consensus/NN motif/NN)) (PP through/IN (NP a/DT (ADJP highly/RB conserved/VBN) C4/NN zinc/NN finger/NN DNA/NN binding/NN domain/NN)))))))) ./.)
(S (NP-SBJ-18 (NP (NP One/CD member/NN) (PP of/IN (NP this/DT multigene/JJ family/NN))) ,/, (NP GATA-3/NN) ,/,) (VP is/VBZ (ADVP-PRD most/RBS abundantly/RB) (VP expressed/VBN (NP *-18/-NONE-) (PP in/IN (NP (NP T/NN lymphocytes/NNS) ,/, (NP (NP a/DT cellular/JJ target/NN) (PP for/IN (NP (NP (NP human/JJ immunodeficiency/NN virus/NN type/NN 1/CD) (PRN -LRB-/-LRB- (NP HIV-1/NN) -RRB-/-RRB-)) (NP-COOD (NP infection/NN) and/CC (NP replication/NN))))))))) ./.)
(S (NP-SBJ (ADJP In/FW vitro/FW) DNase/NN I/CD footprinting/NN analysis/NN) (VP revealed/VBD (NP (NP six/CD hGATA-3/NN binding/NN sites/NNS) (PP in/IN (NP (NP (NP the/DT U3/NN region/NN) (PRN -LRB-/-LRB- (NP the/DT (ADJP transcriptional/JJ regulatory/JJ) domain/NN) -RRB-/-RRB-)) (PP of/IN (NP the/DT HIV-1/NN LTR/NN)))))) ./.)
(S-COOD (S (NP-SBJ (NP Cotransfection/NN) (PP of/IN (NP an/DT hGATA-3/NN expression/NN plasmid/NN)) (PP with/IN (NP (NP a/DT reporter/NN plasmid/NN) (SBAR (WHNP-19 whose/WP$ transcription/NN) (S (NP-SBJ-20 *T*-19/-NONE-) (VP is/VBZ (VP directed/VBN (NP *-20/-NONE-) (PP by/IN (NP-LGS the/DT HIV-1/NN LTR/NN))))))))) (VP resulted/VBD (PP in/IN (NP (NP (QP 6-/CD to/TO 10-fold/JJ) stimulation/NN) (PP of/IN (NP LTR-mediated/JJ transcription/NN)))))) ,/, whereas/IN (S (NP-SBJ (NP (ADJP site/NN specific/JJ) mutation/NN) (PP of/IN (NP these/DT GATA/NN sites/NNS))) (VP resulted/VBD (PP in/IN (NP (NP virtual/JJ abrogation/NN) (PP of/IN (NP (NP the/DT activation/NN) (PP by/IN (NP hGATA-3/NN)))))))) ./.)
(S (ADVP Further/RB) ,/, (NP-SBJ (NP deletion/NN) (PP of/IN (NP the/DT hGATA-3/NN transcriptional/JJ activation/NN domain/NN))) (VP abolished/VBD (NP GATA-dependent/JJ HIV-1/NN trans-activation/NN) ,/, (S (NP-SBJ */-NONE-) (VP showing/VBG (SBAR that/IN (S (NP-SBJ (NP the/DT stimulation/NN) (PP of/IN (NP (NP viral/JJ transcription/NN) (VP observed/VBN (NP */-NONE-))))) (VP is/VBZ (NP-PRD (NP a/DT direct/JJ effect/NN) (PP of/IN (NP cotransfected/VBN hGATA-3/NN))))))))) ./.)
(S (NP-SBJ (NP Introduction/NN) (PP of/IN (NP (NP the/DT HIV-1/NN plasmids/NNS) (SBAR (WHPP-22 in/IN (WHNP which/WDT)) (S (NP-SBJ-21 the/DT GATA/NN sites/NNS) (VP have/VBP (VP been/VBN (VP mutated/VBN (NP *-21/-NONE-) (PP into/IN (NP human/JJ T/NN lymphocytes/NNS)) (PP *T*-22/-NONE-))))))))) (ADVP also/RB) (VP caused/VBD (NP (NP a/DT significant/JJ reduction/NN) (PP in/IN (NP LTR-mediated/JJ transcription/NN))) (PP-COOD (PP at/IN (NP both/CC the/DT basal/JJ level/NN)) and/CC (PP in/IN (NP (ADJP -LRB-/-LRB- (NP-COOD (NP PHA-/NN) plus/CC (NP PMA-/NN)) -RRB-/-RRB- stimulated/JJ) T/NN cells/NNS)))) ./.)
(S (NP-SBJ These/DT observations/NNS) (VP suggest/VBP (SBAR that/IN (S (PP in/IN addition/NN to/TO (NP (NP its/PRP$ normal/JJ role/NN) (PP in/IN (NP T/NN lymphocyte/NN gene/NN regulation/NN)))) ,/, (NP-SBJ hGATA-3/NN) (VP may/MD (ADVP also/RB) (VP play/VB (NP a/DT significant/JJ role/NN) (PP in/IN (NP HIV-1/NN transcriptional/JJ activation/NN))))))) ./.)
